loader
Please Wait
Applying Filters...

Athena Athena

X

Looking for Prestwick3_001026? Find Controlled & Modified Release used in Prestwick3_001026 to address drug delivery challenges on PharmaCompass.

Filters Filter
Cross PopUp
FILTER :

filter

01 DKSH (2)

02 Gangwal Healthcare (2)

03 Nanjing Well Pharmaceutical (4)

04 Actylis (2)

05 Aeon Procare (2)

06 BASF (4)

07 Finar (4)

08 Kerry (2)

09 Lubrizol Life Science Health (4)

10 Nomisma Healthcare (2)

11 Vertellus (3)

filter

01 Capsule (4)

02 Cream / Lotion / Ointment (4)

03 Emulsion (1)

04 Gel (4)

05 Granule / Pellet (2)

06 Injectable / Parenteral (1)

07 Softgels (1)

08 Solution (1)

09 Tablet (11)

10 Topical Film (1)

11 Transdermal Patch (1)

filter

01 China (4)

02 Germany (4)

03 India (10)

04 Switzerland (2)

05 U.S.A (11)

Close
4

Applications:

PLLA-PEG used in the synthesis of targeted nanoparticles which are used for differential delivery and controlled release of drugs.

Ingredient(s): Poly L Lactide, Polyethylene Glycol Excipient

Dosage Form: Tablet

Category: Controlled & Modified Release

Route of Administration (Grade): Oral, Parenteral
Pharmacopoeia Reference: NA

Technical Specifications: Nano-particles, ultrapure, low-monomer & powder grades

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

TALC

URL Supplier Web Content
LM Application #LearnMore

Applications:

Talc is a widely used as a dissolution retardant in the development of controlled release products. Talc is also used as a lubricant in tablet formulations.

Ingredient(s): Talc Excipient

Dosage Form: Granule / Pellet, Tablet

Category: Controlled & Modified Release, Lubricants & Glidants

Route of Administration (Grade): Oral & Topical
Pharmacopoeia Reference: Not Available

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

PLGA-PEG is used in the synthesis of targeted nanoparticles which are used for differential delivery and controlled release of drugs.

Ingredient(s): Poly-DL-Lactic-co-Glycolic Acid, Polyethylene Glycol Excipients

Dosage Form: Tablet

Category: Controlled & Modified Release

Route of Administration (Grade): Oral, Parenteral
Pharmacopoeia Reference: NA

Technical Specifications: Nano-particles, ultrapure, low-monomer & powder grades.

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

POLYETHYLENE GLYCOL 400 NF

URL Supplier Web Content
LM Application #LearnMore

Ingredient(s): polyethylene glycol

Dosage Form: Capsule, Cream / Lotion / Ointment, Gel, Tablet

Category: Controlled & Modified Release, Topical

Route of Administration (Grade): Topical and Oral
Pharmacopoeia Reference: Not Available

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Immediate Release

Ingredient(s): Hydroxypropyl Methylcellulose, Lactose

Dosage Form: Tablet

Category: Coating Systems & Additives, Controlled & Modified Release

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Customized per requirements

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Immediate Release

Ingredient(s): Glycerol, Unmodified, Hydroxypropyl Methylcellulose

Dosage Form: Tablet

Category: Coating Systems & Additives, Controlled & Modified Release

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Customized per requirements

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

POLYETHYLENE GLYCOL 400 NF

URL Supplier Web Content
LM Application #LearnMore

Applications:

A&C's Polyethylene Glycol 400 USP-NF is a short chain non-ionic surfactant.

Ingredient(s): polyethylene glycol

Dosage Form: Cream / Lotion / Ointment, Gel

Category: Topical

Route of Administration (Grade): Topical, Parenteral
Pharmacopoeia Reference: Not Available

Technical Specifications: Low Endotoxin

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Carbopol® 974P NF polymer is used in oral and mucosal contact applications such as oral liquids, bioadhesive formulations, & extended release tablets. Additionally, it can be used to formulate viscous gels, emulsions & suspensions.

Ingredient(s): Carbomer Homopolymer Type B

Dosage Form: Cream / Lotion / Ointment, Emulsion, Gel, Tablet

Category: Controlled & Modified Release, Topical

Route of Administration (Grade): Oral & Topical
Pharmacopoeia Reference: United States Pharmacopeia/National Formulary (USP/NF) monograph for Carbomer Homopolymer Type B, European Pharmacopeia (Ph. Eur.), India Pharmacopeia (IP), China Pharmacopeia (ChP) mongographs for Carbomers.

Technical Specifications: Viscosity, cP (0.5 wt% at pH 7.5)- 29,400 - 39,400

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Solubility and bioavailability enhancement, ideal for hot melt extrusion (HME)

Ingredient(s): polyethylene glycol, Polyvinyl Acetate

Dosage Form: Solution, Tablet, Topical Film, Transdermal Patch

Category: Controlled & Modified Release, Granulation, Solubilizers

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Polyvinyl caprolactam – polyvinyl acetate – polyethylene glycol graft copolymer

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Post Enquiry
POST ENQUIRY